Description

Titan Tesamorelin is a stabilized synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group. This structural modification enhances its stability and potency, making it a primary focus for research into targeted fat loss.

In clinical and laboratory studies, Tesamorelin is uniquely recognized for its ability to significantly reduce visceral adipose tissue (VAT)—the deep, “stubborn” fat surrounding internal organs—without impacting subcutaneous fat levels. Beyond its lipolytic effects, research into Tesamorelin explores its potential to improve cognitive function in older models and its role in maintaining healthy growth hormone levels. Each vial is lyophilized for maximum purity, ensuring consistent and reproducible laboratory results.

Key Features & Research Focus

• Targeted Lipolysis: Specifically investigated for the reduction of visceral (organ) fat.

• Metabolic Support: Studied for its role in improving lipid profiles and insulin sensitivity.

• Enhanced Stability: Researched for its superior resistance to enzymatic degradation compared to natural GHRH.

• Premium Purity: HPLC-verified at 99%+ to meet the highest laboratory standards.